A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer

被引:70
|
作者
Wu, Yin [1 ,2 ,3 ,4 ]
Biswas, Dhruva [1 ,2 ,5 ]
Usaite, Ieva [1 ]
Angelova, Mihaela [2 ]
Boeing, Stefan [6 ]
Karasaki, Takahiro [1 ,2 ]
Veeriah, Selvaraju [1 ]
Czyzewska-Khan, Justyna [1 ]
Morton, Cienne [3 ]
Joseph, Magdalene [3 ,4 ]
Hessey, Sonya [1 ,7 ]
Reading, James [1 ,8 ]
Georgiou, Andrew [1 ,8 ]
Al-Bakir, Maise [2 ]
Birkbak, Nicolai J. [9 ]
McGranahan, Nicholas [1 ]
Jamal-Hanjani, Mariam [1 ,7 ]
Hackshaw, Allan [10 ,11 ]
Quezada, Sergio A. [8 ]
Hayday, Adrian C. [1 ,3 ,4 ]
Swanton, Charles [1 ,2 ]
机构
[1] UCL, Canc Res UK Lung Canc Ctr Excellence, Canc Inst, London, England
[2] Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England
[3] Kings Coll London, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, London, England
[4] Francis Crick Inst, Immunosurveillance Lab, London, England
[5] UCL, Bill Lyons Informat Ctr, Canc Inst, London, England
[6] Francis Crick Inst, Bioinformat & Biostat & Software Dev & Machine Le, London, England
[7] UCL, Canc Metastasis Lab, Canc Inst, London, England
[8] UCL, Dept Res Haematol, Canc Immunol Unit, Canc Inst, London, England
[9] UCL, Canc Genome Evolut Res Grp, Canc Inst, London, England
[10] UCL, Cancer Res UK, London, England
[11] UCL, Canc Trials Ctr, London, England
基金
英国惠康基金; 英国医学研究理事会; 美国国家卫生研究院; 欧盟地平线“2020”; 欧洲研究理事会;
关键词
PD-1; BLOCKADE; ALPHA-BETA; IFN-GAMMA; DIFFERENTIATION; IMMUNOTHERAPY; LYMPHOCYTES; SENSITIVITY; SIGNATURES; LANDSCAPE; EXPANSION;
D O I
10.1038/s43018-022-00376-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Wu et al. utilize multiparametric analysis of early-stage human NSCLC to characterize a population of V delta 1 T cells displaying a resident memory and effector memory phenotype, which were associated with ongoing remission. Murine tissues harbor signature gamma delta T cell compartments with profound yet differential impacts on carcinogenesis. Conversely, human tissue-resident gamma delta cells are less well defined. In the present study, we show that human lung tissues harbor a resident V delta 1 gamma delta T cell population. Moreover, we demonstrate that V delta 1 T cells with resident memory and effector memory phenotypes were enriched in lung tumors compared with nontumor lung tissues. Intratumoral V delta 1 T cells possessed stem-like features and were skewed toward cytolysis and helper T cell type 1 function, akin to intratumoral natural killer and CD8(+) T cells considered beneficial to the patient. Indeed, ongoing remission post-surgery was significantly associated with the numbers of CD45RA(-)CD27(-) effector memory V delta 1 T cells in tumors and, most strikingly, with the numbers of CD103(+) tissue-resident V delta 1 T cells in nonmalignant lung tissues. Our findings offer basic insights into human body surface immunology that collectively support integrating V delta 1 T cell biology into immunotherapeutic strategies for nonsmall cell lung cancer.
引用
收藏
页码:696 / +
页数:23
相关论文
共 50 条
  • [31] Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer
    Milton, Daniel T.
    Riely, Gregory J.
    Azzoli, Christopher G.
    Gomez, Jorge E.
    Heelan, Robert T.
    Kris, Mark G.
    Krug, Lee M.
    Pao, William
    Pizzo, Barbara
    Rizvi, Naiyer A.
    Miller, Vincent A.
    CANCER, 2007, 110 (03) : 599 - 605
  • [32] Combined modality treatment for locally advanced nonsmall-cell lung cancer
    Kelly, K
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 17 (04) : 349 - 356
  • [33] Liensinine Inhibits Cell Growth and Blocks Autophagic Flux in Nonsmall-Cell Lung Cancer
    Chang, Minghui
    Ding, Shanshan
    Dong, Xiaohan
    Shang, Xiaoling
    Li, Yang
    Xie, Li
    Song, Xingguo
    Song, Xianrang
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [34] Enhanced T Cell Immunity by B7-H4 Downregulation in Nonsmall-cell Lung Cancer Cell Lines
    Sun, S-Q
    Jiang, C-G
    Lin, Y.
    Jin, Y-L
    Huang, P-L
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2012, 40 (02) : 497 - 506
  • [35] Tyrosine kinase inhibitors as induction therapy in nonsmall-cell lung cancer
    Gong, Juejun
    Zhang, Li
    CURRENT OPINION IN ONCOLOGY, 2021, 33 (01) : 55 - 58
  • [36] Maintenance Therapy in Nonsmall-Cell Lung Cancer A New Treatment Paradigm
    Mok, Tony S. K.
    Ramalingam, Suresh S.
    CANCER, 2009, 115 (22) : 5143 - 5154
  • [37] No Somatic Genetic Change in the Paxillin Gene in Nonsmall-Cell Lung Cancer
    Pallier, Karine
    Houllier, Anne-Marie
    Le Corre, Delphine
    Cazes, Aurelie
    Laurent-Puig, Pierre
    Blons, Helene
    MOLECULAR CARCINOGENESIS, 2009, 48 (07) : 581 - 585
  • [38] Centromere protein U expression promotes nonsmall-cell lung cancer cell proliferation through FOXM1 and predicts poor survival
    Wang, Xinxin
    Chen, Diangang
    Gao, Jianbao
    Long, Haixia
    Zha, Haoran
    Zhang, Anmei
    Shu, Chi
    Zhou, Li
    Yang, Fei
    Zhu, Bo
    Wu, Wei
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 6971 - 6984
  • [39] Racial Disparities and Survival for Nonsmall-Cell Lung Cancer in a Large Cohort of Black and White Elderly Patients
    Hardy, Dale
    Xia, Rui
    Liu, Chih-Chin
    Cormier, Janice N.
    Nurgalieva, Zhannat
    Du, Xianglin L.
    CANCER, 2009, 115 (20) : 4807 - 4818
  • [40] TNNC1 Reduced Gemcitabine Sensitivity of Nonsmall-Cell Lung Cancer by Increasing Autophagy
    Ye, Xian
    Xie, Guanghui
    Liu, Zhijian
    Tang, Jun
    Cui, Mingyuan
    Wang, Chenbin
    Guo, Chi
    Tang, Jianfeng
    MEDICAL SCIENCE MONITOR, 2020, 26